Histone H3 Ser10 phosphorylation-independent function of Snf1 and Reg1 proteins rescues a gcn5- mutant in HIS3 expression

401 BCH Building, Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI 48824. .
Molecular and Cellular Biology (Impact Factor: 4.78). 01/2006; 25(23):10566-79. DOI: 10.1128/MCB.25.23.10566-10579.2005
Source: PubMed


Gcn5 protein is a prototypical histone acetyltransferase that controls transcription of multiple yeast genes. To identify
molecular functions that act downstream of or in parallel with Gcn5 protein, we screened for suppressors that rescue the transcriptional
defects of HIS3 caused by a catalytically inactive mutant Gcn5, the E173H mutant. One bypass of Gcn5 requirement gene (BGR) suppressor was mapped to the REG1 locus that encodes a semidominant mutant truncated after amino acid 740. Reg1(1-740) protein does not rescue the complete
knockout of GCN5, nor does it suppress other gcn5− defects, including the inability to utilize nonglucose carbon sources. Reg1(1-740) enhances HIS3 transcription while HIS3 promoter remains hypoacetylated, indicating that a noncatalytic function of Gcn5 is targeted by this suppressor protein.
Reg1 protein is a major regulator of Snf1 kinase that phosphorylates Ser10 of histone H3. However, whereas Snf1 protein is
important for HIS3 expression, replacing Ser10 of H3 with alanine or glutamate neither attenuates nor augments the BGR phenotypes. Overproduction of Snf1 protein also preferentially rescues the E173H allele. Biochemically, both Snf1 and Reg1(1-740)
proteins copurify with Gcn5 protein. Snf1 can phosphorylate recombinant Gcn5 in vitro. Together, these data suggest that Reg1
and Snf1 proteins function in an H3 phosphorylation-independent pathway that also involves a noncatalytic role played by Gcn5

6 Reads
  • Source
    • "Surprisingly, pre-IL-1α significantly rescued growth defects of the snf1-108 strain but not the snf1Δ mutant strain on glycerol agar plates containing 3-AT. These results provide another evidence supporting our structural model, and because of the known role of Snf1 and SAGA complex in the regulation of transcription initiation at HIS3 promoter [48], [52], point to the possibility of a competition between pre-IL-1α and Snf1/AMPK for the same binding sites in HAT complexes (Figure 4). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Interleukin-1α (IL-1α) is a proinflammatory cytokine and a key player in host immune responses in higher eukaryotes. IL-1α has pleiotropic effects on a wide range of cell types, and it has been extensively studied for its ability to contribute to various autoimmune and inflammation-linked disorders, including rheumatoid arthritis, Alzheimer's disease, systemic sclerosis and cardiovascular disorders. Interestingly, a significant proportion of IL-1α is translocated to the cell nucleus, in which it interacts with histone acetyltransferase complexes. Despite the importance of IL-1α, little is known regarding its binding targets and functions in the nucleus. We took advantage of the histone acetyltransferase (HAT) complexes being evolutionarily conserved from yeast to humans and the yeast SAGA complex serving as an epitome of the eukaryotic HAT complexes. Using gene knock-out technique and co-immunoprecipitation of the IL-1α precursor with TAP-tagged subunits of the yeast HAT complexes, we mapped the IL-1α-binding site to the HAT/Core module of the SAGA complex. We also predicted the 3-D structure of the IL-1α N-terminal domain, and by employing structure similarity searches, we found a similar structure in the C-terminal regulatory region of the catalytic subunit of the AMP-activated/Snf1 protein kinases, which interact with HAT complexes both in mammals and yeast, respectively. This finding is further supported with the ability of the IL-1α precursor to partially rescue growth defects of snf1Δ yeast strains on media containing 3-Amino-1,2,4-triazole (3-AT), a competitive inhibitor of His3. Finally, the careful evaluation of our data together with other published data in the field allows us to hypothesize a new function for the ADA complex in SAGA complex assembly.
    PLoS ONE 08/2012; 7(8):e41801. DOI:10.1371/journal.pone.0041801 · 3.23 Impact Factor
  • Source
    • "Chromatin decompaction and access to specific genomic loci are controlled by post-translational histone modifications, which occur in a dynamic, cell-specific manner in response to external stimuli and affect histone-DNA linkage (16,17). The main post-translational histone modifications described so far include acetylation of histone H3 Lys9 and Lys14, and acetylation of histone H4 Lys5 (18,19) by histone acetyltransferases. In contrast, histone deacetylases (HDACs) catalyze deacetylation. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Huntington's disease (HD) is a neurodegenerative disorder due to abnormal polyglutamine expansion in huntingtin protein (Exp-Htt). This expansion causes protein aggregation, leading to neuronal dysfunction and death. We have previously shown that mitogen- and stress-activated kinase (MSK-1), a nuclear protein kinase involved in chromatin remodeling through histone H3 phosphorylation, is deficient in the striatum of HD patients and model mice. Restoring MSK-1 expression in cultured striatal cells prevented neuronal dysfunction and death induced by Exp-Htt. Here we extend these observations in a rat model of HD based on striatal lentiviral expression of Exp-Htt (LV-Exp-HTT). MSK-1 overexpression attenuated Exp-Htt-induced down-regulation of DARPP-32 expression 4 and 10 weeks after infection and enhanced NeuN staining after 10 weeks. LV-MSK-1 induced constitutive hyperphosphorylation of H3 and cAMP-responsive element binding protein (CREB), indicating that MSK-1 has spontaneous catalytic activity. MSK-1 overexpression also upregulated peroxisome proliferator-activated receptor γ coactivator alpha (PGC-1α), a transcriptional co-activator involved in mitochondrial biogenesis. Chromatin immunoprecipitation indicated that transcriptional regulation of PGC-1α is directly linked to increased binding of MSK-1, along with H3 and CREB phosphorylation of the PGC-1α promoter. MSK-1 knock-out mice showed spontaneous striatal atrophy as they aged, as well as higher susceptibility to systemic administration of the mitochondrial neurotoxin 3-NP. These results indicate that MSK-1 activation is an important and key event in the signaling cascade that regulates PGC-1α expression. Strategies aimed at restoring MSK-1 expression in the striatum might offer a new therapeutic approach to HD.
    Human Molecular Genetics 06/2011; 20(12):2422-34. DOI:10.1093/hmg/ddr148 · 6.39 Impact Factor
  • Source
    • "This interaction may also play a direct role to regulate the Gcn5's HAT activity, thus contributing to the establishment or maintenance of active chromatin. Intriguingly, several studies have also implicated that Gcn5 preferentially acetylate histone H3 that is phosphorylated at S10 [76] [77] [78] [79] [80] [81], suggesting the role of histone H3 phosphorylation on SAGA's HAT activity. Together, these studies demonstrate that the interaction of SAGA with activator drives its recruitment, and subsequently, histone covalent modification leads to its stabilization onto the promoter. "
    [Show abstract] [Hide abstract]
    ABSTRACT: A growing number of human diseases are linked to abnormal gene expression which is largely controlled at the level of transcriptional initiation. The gene-specific activator promotes the initiation of transcription through its interaction with one or more components of the transcriptional initiation machinery, hence leading to stimulated transcriptional initiation or activation. However, all activator proteins do not target the same component(s) of the transcriptional initiation machinery. Rather, they can have different target specificities, and thus, can lead to distinct mechanisms of transcriptional activation. Two such distinct mechanisms of transcriptional activation in yeast are mediated by the SAGA (Spt-Ada-Gcn5-Acetyltransferase) and TFIID (Transcription factor IID) complexes, and are termed as "SAGA-dependent" and "TFIID-dependent" transcriptional activation, respectively. SAGA is the target of the activator in case of SAGA-dependent transcriptional activation, while the targeting of TFIID by the activator leads to TFIID-dependent transcriptional activation. Both the SAGA and TFIID complexes are highly conserved from yeast to human, and play crucial roles in gene activation among eukaryotes. The regulatory mechanisms of eukaryotic transcriptional activation by SAGA and TFIID are discussed here. This article is part of a Special Issue entitled The 26S Proteasome: When degradation is just not enough!
    Biochimica et Biophysica Acta 02/2011; 1809(2):97-108. DOI:10.1016/j.bbagrm.2010.08.009 · 4.66 Impact Factor
Show more

Preview (2 Sources)

6 Reads
Available from